Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$30.83 – $40.57
60% from low
Exchange
ARCX
ETF
Borrow rate
14.89%
Hard to borrow
No company description on file.
No one on the platform currently holds NITE.
No tracked institution reports a position in NITE as of their last filing.
No one on the platform has traded NITE yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Will Tesla's Worst-Ever Q2 Vehicle Sales Drop Shake Its ETFs? $TSLA $VCR $XLY $FDIS $NITE https://talkmarkets.com/content/etfs/will-teslas-worst-ever-q2-vehicle-sales-drop-shake-its-etfs?post=507664&userid=123969
View on StockTwits ↗$TSLA slides 14.3% on June 5 amid Trump-Musk feud — shares gained 0.8% after hours. Is government support at risk? ⚠️ 🔥 Trump's threat to revoke federal subsidies could impact Tesla. 🚀 SpaceX's government contracts might face scrutiny. 🔍 Tesla's AI focus might be its saving grace. See what this means for Tesla-heavy ETFs like $NITE and $XLY here 👉 https://www.zacks.com/commentary/2487085/tesla-stock-slumps-on-trump-musk-feud-buy-the-dip-in-etfs?cid=sm-stocktwits-2-2487085-body&ADID=SYND_STOCKTWITS_TWEET_2_2487085_BODY
View on StockTwits ↗$TESL, $NITE, $XLY, $VCR can help investors tap $TSLA's robotaxi momentum and Musk's renewed focus on AI and business after political exit. Read here https://www.zacks.com/stock/news/2479612/etfs-to-ride-on-teslas-renewed-growth-story?cid=sm-stocktwits-2-2479612-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2479612_TEASER
View on StockTwits ↗Alibaba Jumps Post Q3 Earnings: ETFs To Buy $PGJ $BABA $ONLN $NITE $CGRO https://talkmarkets.com/content/global-markets/alibaba-jumps-post-q3-earnings-etfs-to-buy?post=483705
View on StockTwits ↗@Randy2979 I was in $NITE prior to $IMMU. Did extensive DD and went all-in when stock dipped to $12 in 2018. A year later $BIIB scooped them up. Also had $TRIL on my radar when it dipped sub $10 but funds were tied up and I missed the boat on that one. I love the upside here and am seeing similar patterns. I am confident there was a deal in place last year and PG fumbled the bag for us. Fortunately BP only cares about the science and I firmly believe a deal will get done soon.
View on StockTwits ↗$NITE.X 💎💎DIAMOND HANDS WANTED💎💎 🚀 NITE TOKEN 🚀 $NITE #NITETOKEN #MOONSHOT https://t.me/NiteTokenio https://nitetoken.io/ Low Market Cap 72 hours old and 40 x 🚀🚀🚀💵💵💵💵💵💵🚀🚀🚀🚀
View on StockTwits ↗$NITE a 72 Hr old BSC token has gained major momentum and taking the alt coin by surprise. Up over 1,000% in 72 hours This small group has been very active getting the word out about their project, check them out yourself at https://nitetoken.io
View on StockTwits ↗$NITE https://petition.parliament.uk/petitions/581655/sponsors/new?token=Kz96D0coaR8uQQvJPUHT
View on StockTwits ↗$NITE I can't find this on any of my accounts. Where is this listed n where can I buy?
View on StockTwits ↗@TheAlmighty might be a bit high but $NITE has to be a reasonable benchmark.
View on StockTwits ↗$AGTC most of you probably never heard of $NITE. Similar space, acquired for $900M last year. This is the closest analog, with broader pipeline too. I would not be selling here. The science is good. If you can’t handle ups and downs, don’t invest in biotech.
View on StockTwits ↗@moneyjunkie on $AGTC? Sure, but eventually, there is a breakout. Could be here, who knows. I was in $NITE. Was acquired. Similar area. This one is enormously undervalued, price discovery going on here.
View on StockTwits ↗$NBIX $NTRP $NXTC $NGM $NITE Pharma vaccine companies dont like this company. Yesterday they recieved 14mil grant from Health of Canada to complete stage 2 trials Prime Minister talked about it on National TV 4 days ago FDA and Health of CANADA approved sub study for EBO5 COVID 19 Treatments forSICK ICU patients. Short summary of the company. Reverse merge with Stellar in June 2019 CEO successful business background Market cap $70 million Insiders own more than %50 of shares Low float ONLY 3.9 million NO DEBT $7 mil cash on hand ARDS/Covid antibody drug EB05 Health Canada and FDA approval Phase 2 EB05 Drug already manufactured 👈👈 Manufacturer (Light Chain Bio) located in Europe (Swiss ) Phase 2 trials in 3 different countries.👈👈 Canada, USA and Colombia via JSS Research Org. Phase 2 results and Fund news coming soon. They have other drugs in their pipelines. 👈👈 some quick links below Meet the CEO conference on Nov 6. edesabiotech.com/clinical-p... twitter.com/EdesaBiotech
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.